Biomedical Research Tax Credit: As Treasury Prepares First Awards, BIO Prepares Renewal Campaign
This article was originally published in The Pink Sheet Daily
Executive Summary
Citing survey that finds eligible firms bullish on employment impact of pending tax credits, biotech industry will seek extension and expansion of the $1 billion Therapeutic Discovery Project in 2011.
You may also be interested in...
Health Reform Delivers Cash to 3,000 Biotech/Healthcare Firms; Big Winner Is Immunomedics
Maximum single award was less than $250,000; the number of applications kept individual award levels down.
Health Reform Delivers Cash to 3,000 Biotech/Healthcare Firms; Big Winner Is Immunomedics
Maximum single award was less than $250,000; the number of applications kept individual award levels down.
Health Reform 101: Cashing In On Hidden Financial Aid Provisions
Biopharmas could win grants equivalent to half of their research expenses in 2009 and 2010, plus apply for a slice of the $500 million in new R&D funding available in areas of high medical need, courtesy of the health reform package